Is Max Healthcare Institute the Best Stock in Its Sector? A Look at the Numbers
- October 13, 2026
- Posted by: Ankit Jaiswal
- Category: Market
Max Healthcare Institute CMP Rs 884 (12 Oct 2026). Market cap Rs 86,041 Cr. ROE 13.42%. P/E 59.05x versus Industry P/E 62.56x.
Quick Answer
Max Healthcare Institute is one of the names investors compare when screening the Healthcare sector, built on a 13.42% return on equity and a P/E of 59.05x against an Industry P/E of 62.56x. Whether Max Healthcare Institute is the best stock in its sector depends on whether an investor is optimising for return ratios, valuation, or both. This article breaks down the metrics, including a comparison against named Healthcare sector peers, so you can judge that for yourself.
Is Max Healthcare Institute the best stock in its sector? The stock trades on the NSE at Rs 884 as of 12 October 2026, within its 52-week range of Rs 870.00 to Rs 1,221.90. Max Healthcare Institute Ltd is a private hospital operator running a network of multi-speciality hospitals across several Indian cities.
Max Healthcare Institute sits in the Healthcare sector, and its 13.42% ROE and 59.05x P/E give a starting point for judging where it stands against comparable listed names. The rest of this article compares those numbers against verified peers and the sector’s Industry P/E benchmark.
Also read – Is Abbott India the Best Stock in Its Sector? A Look at the Numbers
Click Here – Get Free Investment Predictions
About Max Healthcare Institute
Max Healthcare Institute Ltd is a private hospital operator running a network of multi-speciality hospitals across several Indian cities. Hospitals are its main business. The stock trades about 28 percent below its 52-week high and about 2 percent above its 52-week low. At a market capitalisation of Rs 86,041 Cr, it is tracked as part of the Healthcare sector on Univest.
Is Max Healthcare Institute the Best Stock in Its Sector?
Max Healthcare Institute makes its case as the best stock in its sector primarily on valuation relative to its Industry P/E, combining a 13.42% ROE with a 59.05x P/E against the sector’s 62.56x Industry P/E. Max Healthcare’s 59.05x P/E is below the 62.56x Industry P/E, with a 13.42% ROE and a debt to equity ratio of 0.32, so it trades slightly below the hospital sector benchmark with a lighter balance sheet than Apollo.
| Metric | Max Healthcare Institute |
|---|---|
| CMP (NSE) | Rs 883.70 |
| 52-Week High / Low | Rs 1,221.90 / Rs 870.00 |
| Market Cap | Rs 86,041 Cr |
| P/E (TTM) vs Industry P/E | 59.05x vs 62.56x |
| P/B | 8.01 |
| ROE | 13.42% |
| EPS (TTM) | Rs 14.97 |
| Dividend Yield | 0.23% |
| Debt to Equity | 0.32 |
Compare Max Healthcare Institute Against Other Healthcare Sector Stocks
How Max Healthcare Institute Compares Against Its Healthcare Sector Peers
The table below sets Max Healthcare Institute against 2 other Healthcare sector names, using the same live data source for every company. A peer average row is included for P/E, ROE and debt to equity, calculated across the 2 peer companies.
| Company | Market Cap (Rs Cr) | P/E | ROE | Debt to Equity |
|---|---|---|---|---|
| Max Healthcare Institute | 86,041 | 59.05 | 13.42% | 0.32 |
| Apollo Hospitals Enterprise | 1,15,315 | 53.09 | 20.48% | 0.90 |
| Fortis Healthcare | 59,272 | 55.37 | 10.53% | 0.35 |
| Peer average (2 companies) | – | 54.23 | 15.50% | 0.62 |
Against this peer set, Max Healthcare Institute’s 13.42% ROE is below the 15.50% peer average, and its P/E of 59.05x runs above the peer average of 54.23x. Max Healthcare’s 59.05x P/E is below the 62.56x Industry P/E, with a 13.42% ROE and a debt to equity ratio of 0.32, so it trades slightly below the hospital sector benchmark with a lighter balance sheet than Apollo.
What Makes Max Healthcare Institute Worth Watching in Healthcare
- Slight discount: A 59.05x P/E sits just below the 62.56x Industry P/E.
- Lighter leverage: A debt to equity ratio of 0.32 is lower than Apollo’s 0.90 in the peer table.
- Moderate returns: A 13.42% ROE is below Apollo’s 20.48% in the peer table.
Max Healthcare Institute Valuation: Is It Justified?
Max Healthcare’s 59.05x P/E is below the 62.56x Industry P/E, with a 13.42% ROE and a debt to equity ratio of 0.32, so it trades slightly below the hospital sector benchmark with a lighter balance sheet than Apollo. As with any single stock, investors should weigh this against their own valuation discipline and risk appetite rather than the sector label alone.
Also read – Is Lupin the Best Stock in Its Sector? A Look at the Numbers
Download the Univest iOS App or Univest Android App to track Max Healthcare Institute and other Healthcare sector stocks.
How to Track Max Healthcare Institute Before You Invest
Before deciding whether Max Healthcare Institute deserves its label as the best stock in its sector for your own portfolio, compare it directly against Healthcare sector peers using the steps below.
- Open the Univest Screener and search for Max Healthcare Institute to view live price, valuation ratios, and peer comparisons within the Healthcare sector.
- Compare its P/E, P/B, and ROE against other Healthcare sector stocks before deciding if the current valuation fits your strategy.
- Set a price alert around key support and resistance zones using the Univest app so you are notified of meaningful moves.
- Open a broking account on Univest if you decide to add the stock, and size the position based on your own risk appetite and portfolio allocation.
Conclusion
Max Healthcare Institute earns a place in the best stock in its sector conversation on the strength of a 13.42% ROE and a P/E of 59.05x against a 62.56x Industry P/E, with named peer comparisons in this article backing up that picture. As with any individual stock decision, this analysis is educational and investors should do their own research or consult a SEBI-registered advisor before investing.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Is Max Healthcare Institute the best stock in its sector?
Ans. Max Healthcare Institute has a 13.42% ROE and trades at 59.05x P/E against a 62.56x Industry P/E, and compares below the peer average ROE of 15.50% in this article’s named comparison, so the answer depends on what an investor is prioritising.
What is the current share price of Max Healthcare Institute?
Ans. Max Healthcare Institute was trading at Rs 883.70 on the NSE as of 12 October 2026, within its 52-week range of Rs 870.00 to Rs 1,221.90.
What sector does Max Healthcare Institute belong to?
Ans. Max Healthcare Institute is classified under the Healthcare sector on Univest.
How does Max Healthcare Institute compare to its sector peers on P/E?
Ans. Max Healthcare Institute’s P/E of 59.05x is above the 54.23x average of the 2 named peers compared in this article.
What is Max Healthcare Institute’s return on equity?
Ans. Max Healthcare Institute reported a return on equity of 13.42%, which is below the 15.50% average of its named peers in this comparison.
Should I invest in Max Healthcare Institute based on its sector position?
Ans. Max Healthcare Institute’s sector position and metrics make it worth researching further, but any investment decision should factor in your own risk appetite, its valuation relative to peers, and independent research or advice from a SEBI-registered advisor.
